tiprankstipranks
Advertisement
Advertisement

TLPPF Stock Latest News

Telix Pharmaceuticals: Buy Rating Reiterated with Unchanged $31 Target Ahead of Key Pixclara Regulatory Catalyst
RatingsTelix Pharmaceuticals: Buy Rating Reiterated with Unchanged $31 Target Ahead of Key Pixclara Regulatory Catalyst
6d ago
Telix outlines H1 2026 progress in radiopharmaceutical and precision medicine units
PremiumCompany Announcements
Telix outlines H1 2026 progress in radiopharmaceutical and precision medicine units
7d ago
Telix swings to profit on strong U.S. radiopharmaceutical sales
PremiumCompany Announcements
Telix swings to profit on strong U.S. radiopharmaceutical sales
7d ago
Telix Advances PDGFR Alpha Imaging Program With New Phase 1 Trial Update
PremiumCompany Announcements
Telix Advances PDGFR Alpha Imaging Program With New Phase 1 Trial Update
12d ago
TLPPF
Telix Sets August Investor Call for H1 2026 Results
PremiumCompany Announcements
Telix Sets August Investor Call for H1 2026 Results
27d ago
Citi’s Sutcliffe Reiterates Buy on Telix as Strong Precision Medicine Sales and R&D Progress Support Unchanged $31 Price Target
PremiumRatingsCiti’s Sutcliffe Reiterates Buy on Telix as Strong Precision Medicine Sales and R&D Progress Support Unchanged $31 Price Target
1M ago
Telix Lifts Q2 Revenue to US$247m as Radiopharma Pipeline Advances
Premium
Company Announcements
Telix Lifts Q2 Revenue to US$247m as Radiopharma Pipeline Advances
1M ago
Telix trims potential dilution as conditional share rights lapse
Premium
Company Announcements
Telix trims potential dilution as conditional share rights lapse
2M ago
Telix Pharmaceuticals Issues New Shares After Conversion of Unquoted Securities
PremiumCompany Announcements
Telix Pharmaceuticals Issues New Shares After Conversion of Unquoted Securities
2M ago
Telix Seeks ASX Quotation for Additional Ordinary Shares
PremiumCompany Announcements
Telix Seeks ASX Quotation for Additional Ordinary Shares
2M ago
Citi Group Entities Exit Substantial Holder Status in Telix Pharmaceuticals
PremiumCompany Announcements
Citi Group Entities Exit Substantial Holder Status in Telix Pharmaceuticals
2M ago
Citigroup Entities Exit Substantial Holder Status in Telix Pharmaceuticals
PremiumCompany Announcements
Citigroup Entities Exit Substantial Holder Status in Telix Pharmaceuticals
2M ago
Telix Director David Gill Increases Stake With Nasdaq ADS Purchase
PremiumCompany AnnouncementsTelix Director David Gill Increases Stake With Nasdaq ADS Purchase
2M ago
Telix Issues New Tranche of Unquoted Equity Under Employee Incentive Schemes
Premium
Company Announcements
Telix Issues New Tranche of Unquoted Equity Under Employee Incentive Schemes
3M ago
Telix boosts CEO equity incentives with new long-term rights grant
Premium
Company Announcements
Telix boosts CEO equity incentives with new long-term rights grant
3M ago
Telix Grants Share Appreciation Rights to Director Marie McDonald
PremiumCompany Announcements
Telix Grants Share Appreciation Rights to Director Marie McDonald
3M ago
Telix Grants Share Appreciation Rights to Director Jellison After AGM Approval
PremiumCompany Announcements
Telix Grants Share Appreciation Rights to Director Jellison After AGM Approval
3M ago
Telix Grants Share Appreciation Rights to Director Maria Rivas
PremiumCompany Announcements
Telix Grants Share Appreciation Rights to Director Maria Rivas
3M ago
Telix Grants Share Appreciation Rights to Director David Gill
PremiumCompany Announcements
Telix Grants Share Appreciation Rights to Director David Gill
3M ago
Analyst Reiterates Buy on Telix Pharmaceuticals, Sees 38–42% Upside with Unchanged $22.4 Price Target
PremiumRatingsAnalyst Reiterates Buy on Telix Pharmaceuticals, Sees 38–42% Upside with Unchanged $22.4 Price Target
3M ago
Telix Shareholders Back All Resolutions at Annual General Meeting
Premium
Company Announcements
Telix Shareholders Back All Resolutions at Annual General Meeting
3M ago
Telix underscores radiopharma portfolio and regulatory risks at shareholder meeting
Premium
Company Announcements
Telix underscores radiopharma portfolio and regulatory risks at shareholder meeting
3M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >